Adverse events potentially related to immune globulin (human) injection should be reported to the FDA's MedWatch reporting program by telephone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, online ...

April 21, 2010 — The US Food and Drug Administration (FDA) has approved an extended shelf life for 10% liquid intravenous immunoglobulin injection (Privigen, CSL Behring), making it the first ...

Perinatal/Neonatal Case Presentation Open access Published: 30 March 2011 Perinatal/Neonatal Case Presentation Fetal intraperitoneal injection of immunoglobulin diminishes alloimmune hemolysis H ...